Tobi Olaoye

HDAX Therapeutics is a drug discovery startup developing targeted therapeutics to tackle unmet healthcare needs in brain cancers and CNS disorders. Their small molecule inhibitors target HDAC6 in brain cancers / neurodegenerative disorders, more effectively and safely than existing alternatives